Cancer Screening: ACS Releases Annual Summary of Recommendations
Am Fam Physician. 2019 Jun 1;99(11):719-722.
Author disclosure: No relevant financial affiliations.
Key Points for Practice
• The ACS recommends yearly screening for breast cancer in women 45 to 54 years of age and those 40 to 44 years of age who choose earlier screening.
• Women with atypical squamous cells of undetermined significance on cervical cancer screening that were found to be negative for HPV should have repeat screening in three years.
• Physicians should initiate discussions on prostate cancer with those at average risk starting at 50 years of age, at 45 years with higher risk, and at 40 years in those at even higher risk.
From the AFP Editors
The American Cancer Society (ACS) provides a summary of recommendations for cancer screening (Table 1) each year, including any updates and recent data, and advice for when recommendations cannot be made. In addition to this summary, the 2018 report outlines issues that affect screening for breast, cervical, colorectal, and prostate cancer; further explains the 2013 recommendations for lung cancer screening via low-dose computed tomography; compares the ACS recommendations with those of other professional health care organizations; and provides information from the National Health Interview Survey.
American Cancer Society Recommendations for the Early Detection of Cancer in Average-Risk Asymptomatic Adults*
|Cancer site||Population||Test or procedure||Recommendations|
Women 40 to 54 years of age
Should be routinely performed starting at 45 years of age and should be performed annually in women 45 to 54 years of age Should have the opportunity to begin annual screening between 40 and 44 years of age
Women 55 years or older
Should transition to biennial screening or have the opportunity to continue screening annually Mammography should be continued as long as the woman's overall health is good and she has a life expectancy of at least 10 years
Women 21 to 29 years of age
Should be performed starting at 21 years of age and should be performed using conventional or liquid-based options every three years
Women 30 to 65 years of age
Pap smear and HPV DNA test
Combined testing (preferred) should be performed every five years, or a Pap smear alone (acceptable) should be performed every three years (acceptable)
Women older than 65 years
Pap smear and HPV DNA test
Screening should no longer be performed in women older than 65 years who have had at least three consecutive Pap smears with negative results or at least two consecutive HPV tests with negative results and Pap smears within the past 10 years, with the most recent test being performed in the past five years
Women who have had a total hysterectomy
Screening should no longer be performed
Men and women 45 to 75 years of age, for all tests listed
Fecal immunochemical test (annual), high-sensitivity guaiac-based fecal occult blood test (annual), multitarget stool DNA test (every three years per manufacturer's recommendation), colonoscopy (every 10 years), CT colonography (every five years), or flexible sigmoidoscopy (every five years)
Regular screening should be performed with either a high-sensitivity stool-based test or a structural (visual) examination, depending on patient preference and test availability; as part of the screening process, all positive results on noncolonoscopy screening tests should be followed up with timely colonoscopy Screening should be continued until 75 years of age in patients in good health with a life expectancy of more than 10 years
Men and women 76 to 85 years of age
Screening decisions should be individualized, based on patient preference, life expectancy, health status, and screening history; if a decision is made to continue screening, the patient should be offered options as listed above
Men and women older than 85 years
Should be discouraged from continuing screening
Women, at menopause
Should be informed about risks and symptoms of endometrial cancer and strongly encouraged to report any unexpected bleeding or spotting to their physicians
Current or former smokers 55 to 74 years of age in good health with at least a 30-pack-year history of smoking
Low-dose helical CT
Should be performed annually in adults who currently smoke or have quit within the past 15 years, and who have at least a 30-pack-year smoking history; receive evidence-based smoking cessation counseling (if they are current smokers); have undergone a process of informed or shared decision-making that included information about the potential benefits, limitations, and harms of screening with low-dose CT; and have access to a high-volume, high-quality lung cancer screening and treatment center
Men 50 years or older
Prostate-specific antigen test with or without digital rectal examination
Men who have a life expectancy of at least 10 years should have an opportunity to make an informed decision with their health care professional about whether to be s
Coverage of guidelines from other organizations does not imply endorsement by AFP or the AAFP.
This series is coordinated by Sumi Sexton, MD, Editor-in-Chief.
A collection of Practice Guidelines published in AFP is available at https://www.aafp.org/afp/practguide.
Copyright © 2019 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact email@example.com for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions